Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Clin Microbiol ; 62(7): e0047924, 2024 Jul 16.
Artículo en Inglés | MEDLINE | ID: mdl-38856218

RESUMEN

The diagnosis of invasive pulmonary fungal disease depends on histopathology and mycological culture; there are few studies on touch imprints of bronchoscopic biopsies or lung tissue biopsies for the diagnosis of pulmonary filamentous fungi infections. The purpose of the present study was to explore the detection accuracy of rapid on-site evaluation of touch imprints of bronchoscopic biopsies or lung tissue biopsies for the filamentous fungi, and it aims to provide a basis for initiating antifungal therapy before obtaining microbiological evidence. We retrospectively analyzed the diagnosis and treatment of 44 non-neutropenic patients with invasive pulmonary filamentous fungi confirmed by glactomannan assay, histopathology, and culture from February 2017 to December 2023. The diagnostic positive rate and sensitivity of rapid on-site evaluation for these filamentous fungi identification, including diagnostic turnaround time, were calculated. Compared with the final diagnosis, the sensitivity of rapid on-site evaluation was 81.8%, and the sensitivity of histopathology, culture of bronchoalveolar lavage fluid, and glactomannan assay of bronchoalveolar lavage fluid was 86.4%, 52.3%, and 68.2%, respectively. The average turnaround time of detecting filamentous fungi by rapid on-site evaluation was 0.17 ± 0.03 hours, which was significantly faster than histopathology, glactomannan assay, and mycological culture. A total of 29 (76.3%) patients received earlier antifungal therapy based on ROSE diagnosis and demonstrated clinical improvement. Rapid on-site evaluation showed good sensitivity and accuracy that can be comparable to histopathology in identification of pulmonary filamentous fungi. Importantly, it contributed to the triage of biopsies for further microbial culture or molecular detection based on the preliminary diagnosis, and the decision on early antifungal therapy before microbiological evidence is available.


Asunto(s)
Broncoscopía , Hongos , Enfermedades Pulmonares Fúngicas , Pulmón , Sensibilidad y Especificidad , Humanos , Estudios Retrospectivos , Masculino , Femenino , Persona de Mediana Edad , Biopsia , Broncoscopía/métodos , Enfermedades Pulmonares Fúngicas/diagnóstico , Enfermedades Pulmonares Fúngicas/microbiología , Anciano , Hongos/aislamiento & purificación , Hongos/clasificación , Adulto , Pulmón/microbiología , Pulmón/patología , Líquido del Lavado Bronquioalveolar/microbiología , Infecciones Fúngicas Invasoras/diagnóstico , Infecciones Fúngicas Invasoras/microbiología
3.
Rev. cuba. med ; 56(3)jul.-set. 2017. tab
Artículo en Español | LILACS, CUMED | ID: biblio-960614

RESUMEN

Introducción: el diagnóstico temprano de las enfermedades que afectan el parénquima pulmonar ya sean malignas o benignas es de vital importancia para disminuir la mortalidad por estas, la cual es elevada. La biopsia de pulmón transbroncoscópica es fundamental en el diagnóstico de dichas enfermedades con una gran efectividad y un mínimo de invasividad. Objetivo: evaluar los resultados de la biopsia de pulmón transbroncoscópica en lesiones parenquimatosas y sus complicaciones. Métodos: se realizó un estudio descriptivo, de corte transversal retrospectivo, en pacientes a los cuales se les efectuó biopsia de pulmón transbroncoscópica en lesiones parenquimatosas, en el servicio de neumología del hospital Hermanos Ameijeiras, en un periodo de 10 años. Se tomaron en cuenta las variables diagnósticos definitivos, el tipo de afectación radiológica, los factores de riesgo y las complicaciones de dicho proceder. Resultados: se realizó biopsias a 154 pacientes, a 51 se le diagnosticó una enfermedad no maligna y a 78 una enfermedad neoplásica. A 25 pacientes con radiografía torácica anormal no se les estableció diagnóstico con esta técnica. Se obtuvo una muestra adecuada en 145 pacientes (94,1 por ciento) con una exactitud diagnóstica del 83,7 por ciento en enfermedad intersticial, maligna e infecciosa pulmonar. El número de complicaciones fue mínimo. Conclusiones: la biopsia de pulmón transbroncoscópica tiene un alto rendimiento diagnóstico con un número bajo de complicaciones(AU)


Introduction: The early diagnosis of diseases that affect the lung parenchyma, whether malignant or benign, is of vital importance to reduce mortality, which is high. Transbronchoscopic lung biopsy is fundamental in the diagnosis of these diseases since it is highly effective and least invasive. Objective: To evaluate the results of transbronchoscopic lung biopsy in parenchymal lesions and their complications. Methods: A descriptive, retrospective, cross-sectional study was conducted in patients who underwent transbronchoscopic lung biopsy in parenchymal lesions at Hermanos Ameijeiras Hospital Pneumology department, over 10 years. The definitive diagnoses, the type of radiological affectation, the risk factors and the complications of said procedure were taken into account as variables. Results: 154 patients were biopsied, 51 were diagnosed with a non-malignant disease and 78 with a neoplastic disease. Twenty-five patients with abnormal chest radiography were not diagnosed using this technique. An adequate sample was obtained in 145 patients (94.1 percent) with diagnostic accuracy of 83.7 percent in interstitial, malignant and infectious lung disease. The number of complications was minimal. Conclusions: Transbronchoscopic lung biopsy has high diagnostic yield with a low number of complications(AU)


Asunto(s)
Humanos , Masculino , Femenino , Broncoscopía/métodos , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/patología , Biopsia/métodos , Epidemiología Descriptiva , Estudios Transversales , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA